胱抑素C诊断早期糖尿病肾病的临床意义(2)
 |
| 第1页 |
参见附件。
[参考文献]
[1] Suh DC，Kim CM，Choi IS，et al.Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus，1988 to 1994 to 1999 to 2004[J].J Am Geriatr Soc，2008， 56(3)：484-492.
[2] Trivedi H，Pang M，Campbell A，et al.Slowing the progression of chronic renal failure： economic benefits and patients’perspectives[J].Am J Kidney Dis，2002，39(4)：721-729.
[3] Ozden TA，Tekerek H，Bas F，et al.Effect of Hypo -and euthyroid status on serum Cystatin C Levels [J].J Clin Res Pediatr Endocrinol，2010，2(4)：155-158.
[4] Johe GT，Fleming JJ，Talaulikar GS，et al.Measurement of renal function in kidney do-nors usingserum cystatinC and beta[J].Ann Clin Biochem，2003，40(6)：656-658.
[5] Suzuki Y， Matsushita K.Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes[J].Clin Chem Lab Med，2012，50(10)：1833-1839.
[6] Krolewski AS，Warram JH.Serum concentration of cystatin C and risk of end-stage renal disease in diabetes[J].Diabetes Care，2012，35(11)：2311-2316.
[7] Astor BC， Shafi T， Hoogeveen RC，et al.Novel markers of kidney function as predictors of ESRD， cardiovascular disease， and mortality in the general population.[J].Am J Kidney Dis，2012，59(5)：653-662.
[8] Sahakyan K，Lee KE，Shankar A，et al，Serum cystatin C and the incidence of type 2 diabetes mellitus[J].Diabetologia，2011，54(6)：1335-1340.
(收稿日期：2013-02-25)
您现在查看是摘要介绍页，详见PDF附件。